ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 909,92
-0,20%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Evaxion Biotech AS (EVAX) Cours

Evaxion Biotech AS

Evaxion Biotech AS (EVAX)

NASDAQ
0,91
-0,01427
(-1,54%)
Fermé 04 Janvier 10:00PM
Retardé de 15 minutes
0,912
0,002
(0,22%)
Après les heures de négociation: 1:42AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,912
Prix Achat
0,912
Prix Vente
0,93
Volume échangé
155 523
0,8703 Fourchette du Jour 0,938
0,00 Plage de 52 semaines 0,00
Cap du marché
5,089M
Clôture Veille
0,924268
Ouverture
0,92
Dernière Transaction
84
@
0.912
Dernière heure de transaction
Volume financier
US$ 141 400
VWAP
0,909187
Volume moyen (3 m)
-
Actions en circulation
5 580 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
507k
Bénéfice net
-152,41M

À propos de Evaxion Biotech AS

Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in... Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.evaxion-biotech.com
Siège social
Horsholm, Dnk
Fondé
-
Evaxion Biotech AS est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker EVAX. Le dernier cours de clôture d'Evaxion Biotech AS était de US$0,92. Au cours de la dernière année, les actions de Evaxion Biotech AS ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Evaxion Biotech AS compte actuellement 5 580 000 actions en circulation. La capitalisation boursière d'Evaxion Biotech AS est de US$5,16 million.

EVAX Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

30 Décembre 2024
Edgar (US Regulatory)

Evaxion announces plan to implement ADS ratio change

COPENHAGEN, Denmark, December 30, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today...

30 Décembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Décembre 2024
Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

17 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Décembre 2024
Edgar (US Regulatory)

Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity

Evaxion and the European Investment Bank (EIB) are in advanced discussions about conversion of €3.5 million out of Evaxion’s €7 million loan with EIB into an equity-type instrumentSuch conversion...

17 Décembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Décembre 2024
Edgar (US Regulatory)

Evaxion establishes new AI-derived precision cancer vaccine concept

Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical data confirms the...

12 Décembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

09 Décembre 2024
Edgar (US Regulatory)

Evaxion announces 2025 milestones reflecting continued strong strategy execution

With most of Evaxion’s strategic milestones for 2024 now successfully achieved, the company announces milestones for 2025The 2025 key milestones reflect all parts of Evaxion’s strategy for value...

09 Décembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

EVAX - Frequently Asked Questions (FAQ)

What is the current Evaxion Biotech AS share price?
The current share price of Evaxion Biotech AS is US$ 0,912
How many Evaxion Biotech AS shares are in issue?
Evaxion Biotech AS has 5 580 000 shares in issue
What is the market cap of Evaxion Biotech AS?
The market capitalisation of Evaxion Biotech AS is USD 5,16M
What is the 1 year trading range for Evaxion Biotech AS share price?
Evaxion Biotech AS has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Evaxion Biotech AS?
Evaxion Biotech AS reports financial results in USD
What is the latest annual turnover for Evaxion Biotech AS?
The latest annual turnover of Evaxion Biotech AS is USD 507k
What is the latest annual profit for Evaxion Biotech AS?
The latest annual profit of Evaxion Biotech AS is USD -152,41M
What is the registered address of Evaxion Biotech AS?
The registered address for Evaxion Biotech AS is DR. NEERGAARDS VEJ 5F, HORSHOLM, 2970
What is the Evaxion Biotech AS website address?
The website address for Evaxion Biotech AS is www.evaxion-biotech.com
Which industry sector does Evaxion Biotech AS operate in?
Evaxion Biotech AS operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,91M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,26M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,79M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,58M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,26M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,49M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,58M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,91M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
EVAX
Evaxion Biotech AS
BIT
P1SRA7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés